Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Mapping Putative B-Cell Zika Virus NS1 Epitopes Provides Molecular Basis for Anti-NS1 Antibody Discrimination between Zika and Dengue Viruses.

Freire MCLC, Pol-Fachin L, Coêlho DF, Viana IFT, Magalhães T, Cordeiro MT, Fischer N, Loeffler FF, Jaenisch T, Franca RF, Marques ETA, Lins RD.

ACS Omega. 2017 Jul 31;2(7):3913-3920. doi: 10.1021/acsomega.7b00608. Epub 2017 Jul 25.

2.

Detection of IgG3 antibodies specific to the human immunodeficiency virus type 1 (HIV-1) p24 protein as marker for recently acquired infection.

Viana IFT, Coêlho DF, Palma ML, Nascimento EJM, Gu G, Lima LFO, Foti L, Krieger MA, Pilcher C, Calzavara-Silva CE, Mailliard RB, Rinaldo CR, Dhalia R, Marques ETA.

Epidemiol Infect. 2018 Jul;146(10):1293-1300. doi: 10.1017/S0950268818001218. Epub 2018 Jun 21.

PMID:
29925445
3.

Development of antibody biomarkers of long term and recent dengue virus infections.

Nascimento EJM, Huleatt JW, Cordeiro MT, Castanha PMS, George JK, Grebe E, Welte A, Brown M, Burke DS, Marques ETA.

J Virol Methods. 2018 Jul;257:62-68. doi: 10.1016/j.jviromet.2018.04.009. Epub 2018 Apr 21.

4.

Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virus.

Nascimento EJM, George JK, Velasco M, Bonaparte MI, Zheng L, DiazGranados CA, Marques ETA, Huleatt JW.

J Virol Methods. 2018 Jul;257:48-57. doi: 10.1016/j.jviromet.2018.03.007. Epub 2018 Mar 19.

5.

External Quality Assessment for Zika Virus Molecular Diagnostic Testing, Brazil.

Fischer C, Pedroso C, Mendrone A Jr, Bispo de Filippis AM, Vallinoto ACR, Ribeiro BM, Durigon EL, Marques ETA Jr, Campos GS, Viana IFT, Levi JE, Scarpelli LC, Nogueira ML, Bastos MS, Souza NCS, Khouri R, Lira S, Komninakis SV, Baronti C, Charrel RN, Kümmerer BM, Drosten C, Brites C, de Lamballerie X, Niedrig M, Netto EM, Drexler JF.

Emerg Infect Dis. 2018 May;24(5). doi: 10.3201/eid2405.171747. Epub 2018 May 17.

6.

Tradition and innovation in development of a Zika vaccine.

Marques ETA, Burke DS.

Lancet. 2018 Feb 10;391(10120):516-517. doi: 10.1016/S0140-6736(17)33107-0. Epub 2017 Dec 5. No abstract available.

PMID:
29217377
7.

Zika virus displacement by a chikungunya outbreak in Recife, Brazil.

Magalhaes T, Braga C, Cordeiro MT, Oliveira ALS, Castanha PMS, Maciel APR, Amancio NML, Gouveia PN, Peixoto-da-Silva VJ Jr, Peixoto TFL, Britto H, Lima PV, Lima ARS, Rosenberger KD, Jaenisch T, Marques ETA.

PLoS Negl Trop Dis. 2017 Nov 6;11(11):e0006055. doi: 10.1371/journal.pntd.0006055. eCollection 2017 Nov.

8.

Interplay between Keratinocytes and Myeloid Cells Drives Dengue Virus Spread in Human Skin.

Duangkhae P, Erdos G, Ryman KD, Watkins SC, Falo LD Jr, Marques ETA Jr, Barratt-Boyes SM.

J Invest Dermatol. 2018 Mar;138(3):618-626. doi: 10.1016/j.jid.2017.10.018. Epub 2017 Oct 26.

PMID:
29106931
9.

Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum.

Bosch I, de Puig H, Hiley M, Carré-Camps M, Perdomo-Celis F, Narváez CF, Salgado DM, Senthoor D, O'Grady M, Phillips E, Durbin A, Fandos D, Miyazaki H, Yen CW, Gélvez-Ramírez M, Warke RV, Ribeiro LS, Teixeira MM, Almeida RP, Muñóz-Medina JE, Ludert JE, Nogueira ML, Colombo TE, Terzian ACB, Bozza PT, Calheiros AS, Vieira YR, Barbosa-Lima G, Vizzoni A, Cerbino-Neto J, Bozza FA, Souza TML, Trugilho MRO, de Filippis AMB, de Sequeira PC, Marques ETA, Magalhaes T, Díaz FJ, Restrepo BN, Marín K, Mattar S, Olson D, Asturias EJ, Lucera M, Singla M, Medigeshi GR, de Bosch N, Tam J, Gómez-Márquez J, Clavet C, Villar L, Hamad-Schifferli K, Gehrke L.

Sci Transl Med. 2017 Sep 27;9(409). pii: eaan1589. doi: 10.1126/scitranslmed.aan1589.

PMID:
28954927
10.

Enhancement of Zika Infection by Dengue-Specific Antibodies Does Not Alter the Production of Interleukin 6 in FcγRII-Expressing K562 Cells.

Castanha PMS, Nascimento EJM, Braga C, Cordeiro MT, de Carvalho OV, de Mendonça LR, Azevedo EAN, França RFO, Dhalia R, Marques ETA.

J Infect Dis. 2017 Sep 1;216(5):614-615. doi: 10.1093/infdis/jix346. No abstract available.

11.

Incidence and risk factors for Dengue virus (DENV) infection in the first 2 years of life in a Brazilian prospective birth cohort.

Castanha PMS, Montarroyos UR, Silveira SMM, Albuquerque GDM, Mello MJG, Lopes KGS, Cordeiro MT, Marques ETA, Martelli CMT, Braga C.

Epidemiol Infect. 2017 Oct;145(14):2971-2979. doi: 10.1017/S095026881700214X. Epub 2017 Sep 18.

PMID:
28918772
12.

Mosquito-borne and sexual transmission of Zika virus: Recent developments and future directions.

Magalhaes T, Foy BD, Marques ETA, Ebel GD, Weger-Lucarelli J.

Virus Res. 2018 Aug 2;254:1-9. doi: 10.1016/j.virusres.2017.07.011. Epub 2017 Jul 11. Review.

PMID:
28705681
13.

Central and peripheral nervous system involvement caused by Zika and chikungunya coinfection.

Brito CAA, Azevedo F, Cordeiro MT, Marques ETA Jr, Franca RFO.

PLoS Negl Trop Dis. 2017 Jul 13;11(7):e0005583. doi: 10.1371/journal.pntd.0005583. eCollection 2017 Jul. No abstract available.

14.

Establishment and cryptic transmission of Zika virus in Brazil and the Americas.

Faria NR, Quick J, Claro IM, Thézé J, de Jesus JG, Giovanetti M, Kraemer MUG, Hill SC, Black A, da Costa AC, Franco LC, Silva SP, Wu CH, Raghwani J, Cauchemez S, du Plessis L, Verotti MP, de Oliveira WK, Carmo EH, Coelho GE, Santelli ACFS, Vinhal LC, Henriques CM, Simpson JT, Loose M, Andersen KG, Grubaugh ND, Somasekar S, Chiu CY, Muñoz-Medina JE, Gonzalez-Bonilla CR, Arias CF, Lewis-Ximenez LL, Baylis SA, Chieppe AO, Aguiar SF, Fernandes CA, Lemos PS, Nascimento BLS, Monteiro HAO, Siqueira IC, de Queiroz MG, de Souza TR, Bezerra JF, Lemos MR, Pereira GF, Loudal D, Moura LC, Dhalia R, França RF, Magalhães T, Marques ET Jr, Jaenisch T, Wallau GL, de Lima MC, Nascimento V, de Cerqueira EM, de Lima MM, Mascarenhas DL, Neto JPM, Levin AS, Tozetto-Mendoza TR, Fonseca SN, Mendes-Correa MC, Milagres FP, Segurado A, Holmes EC, Rambaut A, Bedford T, Nunes MRT, Sabino EC, Alcantara LCJ, Loman NJ, Pybus OG.

Nature. 2017 Jun 15;546(7658):406-410. doi: 10.1038/nature22401. Epub 2017 May 24.

15.

Rapid and specific detection of Asian- and African-lineage Zika viruses.

Chotiwan N, Brewster CD, Magalhaes T, Weger-Lucarelli J, Duggal NK, Rückert C, Nguyen C, Garcia Luna SM, Fauver JR, Andre B, Gray M, Black WC 4th, Kading RC, Ebel GD, Kuan G, Balmaseda A, Jaenisch T, Marques ETA, Brault AC, Harris E, Foy BD, Quackenbush SL, Perera R, Rovnak J.

Sci Transl Med. 2017 May 3;9(388). pii: eaag0538. doi: 10.1126/scitranslmed.aag0538.

16.

Zika puzzle in Brazil: peculiar conditions of viral introduction and dissemination - A Review.

Possas C, Brasil P, Marzochi MC, Tanuri A, Martins RM, Marques ET, Bonaldo MC, Ferreira AG, Lourenço-de-Oliveira R, Nogueira RMR, Sequeira PC, Marzochi KB, Homma A.

Mem Inst Oswaldo Cruz. 2017 May;112(5):319-327. doi: 10.1590/0074-02760160510. Epub 2017 Apr 6. Review.

17.

Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo.

Palma ML, Duangkhae P, Douradinha B, Viana IFT, Rigato PO, Dhalia R, Mailliard RB, Barratt-Boyes SM, Nascimento EJM, Oshiro TM, da Silva Duarte AJ, Marques ETA.

Gene Ther. 2017 Jun;24(6):342-352. doi: 10.1038/gt.2017.25. Epub 2017 Apr 17.

PMID:
28414303
18.

Risk of microcephaly after Zika virus infection in Brazil, 2015 to 2016.

Jaenisch T, Rosenberger KD, Brito C, Brady O, Brasil P, Marques ET.

Bull World Health Organ. 2017 Mar 1;95(3):191-198. doi: 10.2471/BLT.16.178608.

19.

Dengue Virus-Specific Antibodies Enhance Brazilian Zika Virus Infection.

Castanha PMS, Nascimento EJM, Braga C, Cordeiro MT, de Carvalho OV, de Mendonça LR, Azevedo EAN, França RFO, Dhalia R, Marques ETA.

J Infect Dis. 2017 Mar 1;215(5):781-785. doi: 10.1093/infdis/jiw638.

20.

Results of a Zika Virus (ZIKV) Immunoglobulin M-Specific Diagnostic Assay Are Highly Correlated With Detection of Neutralizing Anti-ZIKV Antibodies in Neonates With Congenital Disease.

Cordeiro MT, Brito CA, Pena LJ, Castanha PM, Gil LH, Lopes KG, Dhalia R, Meneses JA, Ishigami AC, Mello LM, Alencar LX, Guarines KM, Rodrigues LC, Marques ET.

J Infect Dis. 2016 Dec 15;214(12):1897-1904. Epub 2016 Oct 5.

PMID:
27923950
21.

1H Nuclear Magnetic Resonance Metabolomics of Plasma Unveils Liver Dysfunction in Dengue Patients.

El-Bacha T, Struchiner CJ, Cordeiro MT, Almeida FCL, Marques ET Jr, Da Poian AT.

J Virol. 2016 Jul 27;90(16):7429-7443. doi: 10.1128/JVI.00187-16. Print 2016 Aug 15.

22.

Dendritic cells primed with a chimeric plasmid containing HIV-1-gag associated with lysosomal-associated protein-1 (LAMP/gag) is a potential therapeutic vaccine against HIV.

Lucas CG, Matassoli FL, Peçanha LM, Santillo BT, Oliveira LM, Oshiro TM, Marques ET Jr, Oxenius A, de Arruda LB.

FASEB J. 2016 Aug;30(8):2970-84. doi: 10.1096/fj.201500059. Epub 2016 May 19.

PMID:
27199296
23.

Selection of a potential diagnostic biomarker for HIV infection from a random library of non-biological synthetic peptoid oligomers.

Gearhart TL, Montelaro RC, Schurdak ME, Pilcher CD, Rinaldo CR, Kodadek T, Park Y, Islam K, Yurko R, Marques ET Jr, Burke DS.

J Immunol Methods. 2016 Aug;435:85-9. doi: 10.1016/j.jim.2016.05.001. Epub 2016 May 12.

24.

Positive IgM for Zika virus in the cerebrospinal fluid of 30 neonates with microcephaly in Brazil.

Cordeiro MT, Pena LJ, Brito CA, Gil LH, Marques ET.

Lancet. 2016 Apr 30;387(10030):1811-2. doi: 10.1016/S0140-6736(16)30253-7. Epub 2016 Apr 18. No abstract available.

PMID:
27103126
25.

Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection.

Bayer A, Lennemann NJ, Ouyang Y, Bramley JC, Morosky S, Marques ET Jr, Cherry S, Sadovsky Y, Coyne CB.

Cell Host Microbe. 2016 May 11;19(5):705-12. doi: 10.1016/j.chom.2016.03.008. Epub 2016 Apr 5.

26.

Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants.

Castanha PM, Braga C, Cordeiro MT, Souza AI, Silva CD Jr, Martelli CM, van Panhuis WG, Nascimento EJ, Marques ET.

J Infect Dis. 2016 Jul 15;214(2):265-72. doi: 10.1093/infdis/jiw143. Epub 2016 Apr 7.

27.

Computed Tomographic Findings in Microcephaly Associated with Zika Virus.

Hazin AN, Poretti A, Di Cavalcanti Souza Cruz D, Tenorio M, van der Linden A, Pena LJ, Brito C, Gil LH, de Barros Miranda-Filho D, Marques ET, Turchi Martelli CM, Alves JG, Huisman TA; Microcephaly Epidemic Research Group.

N Engl J Med. 2016 Jun 2;374(22):2193-5. doi: 10.1056/NEJMc1603617. Epub 2016 Apr 6. No abstract available.

28.

Clinical evaluation of dengue and identification of risk factors for severe disease: protocol for a multicentre study in 8 countries.

Jaenisch T, Tam DT, Kieu NT, Van Ngoc T, Nam NT, Van Kinh N, Yacoub S, Chanpheaktra N, Kumar V, See LL, Sathar J, Sandoval EP, Alfaro GM, Laksono IS, Mahendradhata Y, Sarker M, Ahmed F, Caprara A, Benevides BS, Marques ET, Magalhaes T, Brasil P, Netto M, Tami A, Bethencourt SE, Guzman M, Simmons C, Quyen NT, Merson L, Dung NT, Beck D, Wirths M, Wolbers M, Lam PK, Rosenberger K, Wills B.

BMC Infect Dis. 2016 Mar 11;16:120. doi: 10.1186/s12879-016-1440-3.

29.

Teratogenic effects of the Zika virus and the role of the placenta.

Adibi JJ, Marques ET Jr, Cartus A, Beigi RH.

Lancet. 2016 Apr 9;387(10027):1587-90. doi: 10.1016/S0140-6736(16)00650-4. Epub 2016 Mar 4.

PMID:
26952548
30.

Prospective birth cohort in a hyperendemic dengue area in Northeast Brazil: methods and preliminary results.

Braga C, Albuquerque Mde F, Cordeiro MT, Castanha PM, Ramesh A, Alexander N, Mello MJ, Marques ET Jr, Martelli CM.

Cad Saude Publica. 2016 Jan;32(1). pii: S0102-311X2016000100601. doi: 10.1590/0102-311X00095815. Epub 2016 Feb 12.

31.

Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement?

Palma ML, Zamith-Miranda D, Martins FS, Bozza FA, Nimrichter L, Montero-Lomeli M, Marques ET Jr, Douradinha B.

Appl Microbiol Biotechnol. 2015 Aug;99(16):6563-70. doi: 10.1007/s00253-015-6776-x. Epub 2015 Jul 4. Review.

PMID:
26142388
32.

A DNA vaccine against yellow fever virus: development and evaluation.

Maciel M Jr, Cruz Fda S, Cordeiro MT, da Motta MA, Cassemiro KM, Maia Rde C, de Figueiredo RC, Galler R, Freire Mda S, August JT, Marques ET, Dhalia R.

PLoS Negl Trop Dis. 2015 Apr 13;9(4):e0003693. doi: 10.1371/journal.pntd.0003693. eCollection 2015 Apr.

33.

Molecular classification of outcomes from dengue virus -3 infections.

Brasier AR, Zhao Y, Wiktorowicz JE, Spratt HM, Nascimento EJ, Cordeiro MT, Soman KV, Ju H, Recinos A 3rd, Stafford S, Wu Z, Marques ET Jr, Vasilakis N.

J Clin Virol. 2015 Mar;64:97-106. doi: 10.1016/j.jcv.2015.01.011. Epub 2015 Jan 17.

34.

Assessing protein conformational sampling and structural stability via de novo design and molecular dynamics simulations.

Cunha KC, Rusu VH, Viana IF, Marques ET, Dhalia R, Lins RD.

Biopolymers. 2015 Jun;103(6):351-61. doi: 10.1002/bip.22626.

PMID:
25677872
35.

Dengue virus specific dual HLA binding T cell epitopes induce CD8+ T cell responses in seropositive individuals.

Comber JD, Karabudak A, Huang X, Piazza PA, Marques ET, Philip R.

Hum Vaccin Immunother. 2014;10(12):3531-43. doi: 10.4161/21645515.2014.980210.

36.

A two-plasmid strategy for engineering a dengue virus type 3 infectious clone from primary Brazilian isolate.

Santos JJ, Cordeiro MT, Bertani GR, Marques ET, Gil LH.

An Acad Bras Cienc. 2014 Dec;86(4):1749-59. doi: 10.1590/0001-3765201420130332. Epub 2014 Nov 11.

37.

Draft Genome Sequence of the Probiotic Yeast Saccharomyces cerevisiae var. boulardii Strain ATCC MYA-796.

Batista TM, Marques ET Jr, Franco GR, Douradinha B.

Genome Announc. 2014 Dec 18;2(6). pii: e01345-14. doi: 10.1128/genomeA.01345-14.

38.

A two-plasmid strategy for engineering a dengue virus type 3 infectious clone from primary Brazilian isolate.

Santos JJ, Cordeiro MT, Bertani GR, Marques ET, Gil LH.

An Acad Bras Cienc. 2014 Nov 11;0:0. [Epub ahead of print]

39.

Risk of dengue for tourists and teams during the World Cup 2014 in Brazil.

van Panhuis WG, Hyun S, Blaney K, Marques ET Jr, Coelho GE, Siqueira JB Jr, Tibshirani R, da Silva JB Jr, Rosenfeld R.

PLoS Negl Trop Dis. 2014 Jul 31;8(7):e3063. doi: 10.1371/journal.pntd.0003063. eCollection 2014.

40.

Emerging concepts in dengue pathogenesis: interplay between plasmablasts, platelets, and complement in triggering vasculopathy.

Nascimento EJ, Hottz ED, Garcia-Bates TM, Bozza F, Marques ET Jr, Barratt-Boyes SM.

Crit Rev Immunol. 2014;34(3):227-40. Review.

PMID:
24941075
41.

Regulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP-1) enhance Gag-specific immune response.

Godinho RM, Matassoli FL, Lucas CG, Rigato PO, Gonçalves JL, Sato MN, Maciel M Jr, Peçanha LM, August JT, Marques ET Jr, de Arruda LB.

PLoS One. 2014 Jun 16;9(6):e99887. doi: 10.1371/journal.pone.0099887. eCollection 2014.

42.

Construction and characterisation of a complete reverse genetics system of dengue virus type 3.

Santos JJ, Cordeiro MT, Bertani GR, Marques ET, Gil LH.

Mem Inst Oswaldo Cruz. 2013 Dec;108(8):983-91.

43.

C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells.

Douradinha B, McBurney SP, Soares de Melo KM, Smith AP, Krishna NK, Barratt-Boyes SM, Evans JD, Nascimento EJ, Marques ET Jr.

Virus Res. 2014 Jan 22;179:231-4. doi: 10.1016/j.virusres.2013.11.007. Epub 2013 Nov 15.

44.

Identification of conserved and HLA promiscuous DENV3 T-cell epitopes.

Nascimento EJ, Mailliard RB, Khan AM, Sidney J, Sette A, Guzman N, Paulaitis M, de Melo AB, Cordeiro MT, Gil LV, Lemonnier F, Rinaldo C, August JT, Marques ET Jr.

PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2497. doi: 10.1371/journal.pntd.0002497. eCollection 2013.

45.

Potential biomarkers for the clinical prognosis of severe dengue.

Silva MM, Gil LH, Marques ET Jr, Calzavara-Silva CE.

Mem Inst Oswaldo Cruz. 2013 Sep;108(6):755-62. doi: 10.1590/0074-0276108062013012.

46.

Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.

Douradinha B, Reis VC, Rogers MB, Torres FA, Evans JD, Marques ET Jr.

Bioengineered. 2014 Jan-Feb;5(1):21-9. doi: 10.4161/bioe.26271. Epub 2013 Sep 5.

47.

Selective induction of CTL helper rather than killer activity by natural epitope variants promotes dendritic cell-mediated HIV-1 dissemination.

Mailliard RB, Smith KN, Fecek RJ, Rappocciolo G, Nascimento EJ, Marques ET, Watkins SC, Mullins JI, Rinaldo CR.

J Immunol. 2013 Sep 1;191(5):2570-80. doi: 10.4049/jimmunol.1300373. Epub 2013 Aug 2.

48.

HLA-B∗44 Is Associated with Dengue Severity Caused by DENV-3 in a Brazilian Population.

Xavier Eurico de Alencar L, de Mendonça Braga-Neto U, José Moura do Nascimento E, Tenório Cordeiro M, Maria Silva A, Alexandre Antunes de Brito C, da Silva Mda P, Gil LH, Montenegro SM, Marques ET Jr.

J Trop Med. 2013;2013:648475. doi: 10.1155/2013/648475. Epub 2013 Jun 2.

49.

Complement factor H gene (CFH) polymorphisms C-257T, G257A and haplotypes are associated with protection against severe dengue phenotype, possible related with high CFH expression.

Pastor AF, Rodrigues Moura L, Neto JW, Nascimento EJ, Calzavara-Silva CE, Gomes AL, Silva AM, Cordeiro MT, Braga-Neto U, Crovella S, Gil LH, Marques ET Jr, Acioli-Santos B.

Hum Immunol. 2013 Sep;74(9):1225-30. doi: 10.1016/j.humimm.2013.05.005. Epub 2013 Jun 6.

50.

Construction of yellow fever virus subgenomic replicons by yeast-based homologous recombination cloning technique.

Queiroz SR, Silva AN, Santos JJ, Marques ET Jr, Bertani GR, Gil LH.

An Acad Bras Cienc. 2013 Mar;85(1):159-68. Epub 2013 Mar 1.

Supplemental Content

Loading ...
Support Center